What long-term risks have been linked to metformin?
Long-term use of metformin is generally associated with two main, well-described risks: vitamin B12 deficiency and gastrointestinal side effects that can persist or worsen over time.
Vitamin B12 deficiency
Metformin can reduce vitamin B12 absorption, which may lead to deficiency after months to years of treatment. This matters because low B12 can cause anemia and nerve-related symptoms such as tingling, numbness, or balance problems. Clinicians often monitor B12 levels in people who have symptoms or who are at higher risk.
Persistent or chronic gastrointestinal effects
Some people continue to experience nausea, diarrhea, abdominal discomfort, or a loss of appetite with long-term use—especially early in treatment or at higher doses. These effects are commonly mitigated by starting with a lower dose, taking doses with meals, or switching to an extended-release formulation.
What are the serious complications people worry about most?
Lactic acidosis (the risk that drives most fear)
The rare but serious concern with metformin is lactic acidosis. It is uncommon, but the risk rises when metformin builds up in the body, which can happen in situations such as significant kidney impairment, severe dehydration, or serious illness that affects oxygen delivery to tissues. Clinicians typically avoid metformin when kidney function is too low and use temporary discontinuation during certain acute illnesses.
Kidney function decline
Metformin is not known to directly damage kidneys, but safe use depends on baseline kidney function and ongoing monitoring. When kidney function worsens, the risk of adverse effects increases, which is why dose adjustments or discontinuation may be needed.
Who is at higher risk for long-term metformin problems?
Risk tends to be higher for people who:
- Have impaired kidney function or fluctuate between good and poor hydration (for example, during frequent illnesses).
- Take metformin for many years without checking B12.
- Have symptoms consistent with B12 deficiency (fatigue from anemia or nerve symptoms).
- Use medications or have conditions that raise B12 risk (for example, certain gastric conditions or interacting therapies), since low B12 can be easier to trigger.
How can patients reduce long-term risks?
Common risk-reduction steps include:
- Using extended-release metformin if stomach side effects persist.
- Taking metformin with food to improve tolerability.
- Periodic monitoring of kidney function as advised by a clinician.
- Checking vitamin B12 in higher-risk patients or when symptoms appear, and supplementing if deficiency is found.
What should you do if you’ve been on metformin for years?
If you’re on long-term metformin, the practical next steps usually are:
- Ask your clinician whether you should have kidney function and B12 testing based on your dose and risk factors.
- Report symptoms early—especially numbness/tingling, burning sensations, gait imbalance, unexplained anemia-type fatigue, or persistent diarrhea.
- Review whether any recent illness, surgery, or dehydration should have triggered temporary holding of metformin.
Are there alternatives if long-term risks become a problem?
Yes. Depending on your diabetes type, kidney function, cardiovascular risk, and tolerance, clinicians may adjust therapy by:
- Switching metformin formulation (immediate-release to extended-release).
- Reducing the dose.
- Adding or substituting other glucose-lowering medications if metformin is not safe or not tolerated.
If you share your age, kidney function (eGFR if you know it), metformin dose/formulation (immediate vs extended release), and any symptoms (GI issues, numbness/tingling, fatigue), I can help you identify which long-term risks are most relevant for your situation and what to ask your clinician about next.